The Human Side of Failed Hypertension Treatment

Journal of Clinical Hypertension

Volumn 15, Issue 11, 2013, Pages 762-764

  Weber, Michael A ^a   Oparil, Suzanne ^b  

^a Downstate Health Sciences University   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ANXIETY DISORDER; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DRUG TREATMENT FAILURE; EDITORIAL; EMOTION; HEART INFARCTION; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MAXIMUM TOLERATED DOSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; SELF CONTROL; SELF REPORT; URINALYSIS; WELLBEING; WHITE COAT HYPERTENSION; CARDIOVASCULAR DISEASES; COMPLICATION; PSYCHOLOGY; QUALITY OF LIFE; RISK FACTOR; TREATMENT FAILURE;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; QUALITY OF LIFE; RISK FACTORS; TREATMENT FAILURE;

EID: 84886950391     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12175     Document Type: Editorial

References (19)

1. Oliveria SA, Chen RS, McCarthy BD, et al. Hypertension knowledge, awareness, and attitudes in a hypertensive population. J Gen Intern Med. 2005;20:219-225.
2. Miller NH, Berra K, Long J. Hypertension 2008-awareness, understanding, and treatment of previously diagnosed hypertension in baby boomers and seniors: a survey conducted by Harris Interactive on behalf of the Preventive Cardiovascular Nurses Association. J Clin Hypertens. (Greenwich) 2010;12:328-334.
3. Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003;163:681-687.
4. Wiklund I, Halling K, Rydén-Bergsten T, Fletcher A. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. Blood Press. 1997;6:357-364.
5. Weir MR, Prisant LM, Papademetriou V, et al. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy. Am J Hypertens. 1996;9:854-859.
6. Bulpitt CJ. The effect of lowering blood pressure on quality of life. Curr Hypertens Rep. 2000;2:509.
7. Schmieder RE, Grassi G, Kjeldsen SE. Patients with treatment-resistant hypertension report increased stress and anxiety: a worldwide study. J Hypertens. 2013;31:610-615.
8. Dupuy HJ. The psychological general well being. In: Wenger NK, Mattson ME, Furburg CD, et al, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, NY. LeJacq Publishing Inc; 1984:170-183.
9. Weber MA, Bakris GL, Neutel JM, et al. Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker. J Clin Hypertens (Greenwich). 2003;5:322-329.
10. Calhoun DA, Jones D, Textor S, et al; American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510-e526.
11. Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention; Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
12. Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens. 2005;18:1422-1428.
13. Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet. 2004;19:363.
14. Sleight P, Redon J, Verdecchia P, et al; ONTARGET investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens. 2009;27:1360-1369.
15. Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61-68.
16. Weber MA, Bakris GL, Hester A, et al. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension. Am J Med. 2013;126:501-508.
17. Weber MA, Julius S, Kjeldsen SE, et al. Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy. J Hypertens. 2012;30:2213-2222.
18. de la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898-902.
19. Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31:766-774.